Prime Medicine announces promising preclinical results for a novel AATD treatment using advanced Prime Editing technology, aiming for clinical trials by mid-2026. Prime Medicine, Inc. announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback